PRF1 and neoplasm: To the best of our knowledge, cytotoxic T lymphocyte (CTL) is considered the most pivotal effector cell in anti‐tumor immunity,51 and it is capable of specifically killing tumor cells through the Fas‐FasL and TNF‐TNFR pathway and the perforin/granzyme pathway.